Chronic disease prevalence and burden in elderly men: An analysis of medicare medical claims data

Journal of Health Care Finance

Volumn 33, Issue 4, 2007, Pages 68-78

  Black, Libby ^a   Runken, M Chris ^b   Eaddy, Michael ^c   Shah, Manan ^c  

^a GLAXOSMITHKLINE   (United Kingdom)

^b GLAXOSMITHKLINE   (United States)

^c NONE   (United States)

Author keywords

Cardiovascular disease; Cataract; Chronic disease; Elderly; Hypertension; Medicare; Medicare Modernization Act; Prescription drug coverage; Prostate

Indexed keywords

AGED; ARTICLE; BILLING AND CLAIMS; CARDIOVASCULAR DISEASE; CATARACT; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST OF ILLNESS; DATA BASE; HEALTH CARE MANAGEMENT; HEALTH CARE PERSONNEL; HEART ARRHYTHMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; MEDICARE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOARTHRITIS; PRESCRIPTION; PREVALENCE; PROSTATE CANCER; PROSTATE HYPERTROPHY; SKIN CANCER;

AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICARE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 34447576962     PISSN: 10786767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Agency for Healthcare Research and Quality, "Patient Involvement Key to Better Prostate Care," Press Release (Aug. 22, 1995), Rockville, MD, based on "Prostate Disease: Patient Outcomes Research Team Final Report," Springfield, VA: National Technical Information Service, Publication Number PB95-253811, available at: www.ahrq.gov/news/press/pro2. htm.
2. American Cancer Society, "Facts & Figures 2005: Age-Adjusted Cancer Death Rates," accessed Jan. 6, 2006, at: www.cancer.org/docroot/ MED/content/MED_1_1_Most-Requested_Graphs_and_Figures_2005.asp.
3. G. Apolone, A. Cattaneo, P. Colombo, C. La Vecchia, L. Cavazzuti, and F. Bamfi, "Knowledge and Opinion on Prostate and Prevalence of Self-Reported BPH and Prostate-Related Events: A Cross-Sectional Survey in Italy," European Journal of Cancer Prevention 11 no. 5 (2002): 473-479.
4. P. Baker "Sex and Gender Matter: From Boys to Men: The Future of Men's Health," Conference Report, Medscape Family Medicine/Primary Care 3 no. 2 (2001), accessed Jan. 9, 2006, at: www.medscape.com/viewarticle/ 415037_2/.
5. J. Barkin, M. Guimaraes, G. Jacobi, D. Pushkar, S. Taylor, O.B. van Vierssen Trip, "Alpha-Blocker Therapy can be Withdrawn in the Majority of Men Following Initial Combination Therapy with the Dual 5 Alpha-Reductase Inhibitor Dutasteride," European Urology 44 no. 4 (2003): 461-466.
6. C.A. Barnes, "Disease Staging: A Clinically Orientated Dimension of Case Mix," American Medical Record Association 56 (1985): 22-27.
7. M.J. Barry, "Epidemiology and Natural History of Benign Prostatic Hyperplasia," The Urology Clinics of North America 17 (1990): 495-507.
8. C. Caplan and N. Brangan, "Out-of-Pocket Spending on Health Care by Medicare Beneficiaries Age 65 and Older in 2003," Data Digest 101, Washington, DC: AARP Public Policy Institute, 2004, accessed Jan. 6, 2006, at: www.assets.aarp.org/rgcenter/health/dd101_spending.pdf.
9. Centers for Medicare & Medicaid Services Limited Data Set, accessed Nov. 13, 2006, at: www.cms.hhs.gov/LimitedDataSets.
10. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, J.L. Izzo Jr., et al., Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program Coordinating Committee, "Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure," Hypertension 42 no. 6 (2003): 1206-1252.
11. M.M. Collins, R.S. Stafford, M.P. O'Leary, and M.J. Barry, "How Common is Prostatitis? A National Survey of Physician Visits," Journal of Urology 159 no. 4 (1998): 1224-1228.
12. W.H. Courtenay and R.P. Keeling, "Men, Gender, and Health: Toward an Interdisciplinary Approach," Journal of American College Health 48 no. 6 (2000): 243-246.
13. M.L. Daviglus, K. Liu, P. Greenland, A.R. Dyer, D.B. Garside, L. Manheim, L.P. Lowe, M. Rodin, J. Lubitz, and J. Stamler, "Benefit of a Favorable Cardiovascular Risk-Factor Profile in Middle Age with Respect to Medicare Costs," New England Journal of Medicine 339 no. 16 (1998): 1122-1129.
14. Department of Health & Human Services, Agency for Healthcare Quality and Research, "MEPS - Out of Pocket Health Care Expenses by Age and Insurance Coverage, 2003: Statistical Brief #126, Medical Expenditure Panel Survey," accessed May 23, 2006, at: www.meps.ahrq.gov/papers/st126/ stat126.pdf.
15. M. Desai, L. Pratt, H. Lentzner, and K. Robinson, "Trends in Vision and Hearing among Older Americans," 2001, Centers for Disease Control, National Center for Health Statistics, accessed Jan. 9, 2006, at: www.cdc.gov/nchs/data/ agingtrends/02vision.pdf.
16. C.R. Dolder, "Dutasteride: A Dual 5-Alpha Reductase Inhibitor for the Treatment of Symptomatic Benign Prostatic Hyperplasia," Annals of Pharmacotherapy 40 no. 4 (2006): 658-665.
17. G.M. Felton, M.A. Parsons, and M.G. Bartoces, "Demographic Factors: Interaction Effects on Health-Promoting Behavior and Health-Related Factors," Public Health Nursing 14 (1997): 361-367.
18. T.C. Fenter, M.J. Naslund, M.B. Shah, M.T. Eaddy, and L. Black, "The Cost of Treating the 10 Most Prevalent Diseases in Men 50 Years of Age or Older," American Journal of Managed Care 12 (2006): S90-S98.
19. P.M. Galdas, F. Cheater, and P. Marshall, "Men and Health Help-Seeking Behaviour: Literature Review," Journal of Advanced Nursing 6 (2005): 616-623.
20. J. Gonnella, M. Hornbrook, and D. Louis, "Staging of Disease: A Case-Mix Measurement," Journal of the American Medical Association, 215, 5: 637-644 (1984).
21. J.S. Gonnella, D.Z. Louis, and M.E. Gozum (eds.), Disease Staging Classification and Severity Stratification, Ann Arbor, MI: The Medstat Group, Inc., 1994.
22. T.L. Griebling, "Urologic Diseases in America Project: Trends in Resource Use for Urinary Tract Infections in Men," Journal of Urology 173 no. 4 (2005): 1288-1294.
23. Healthcare Cost & Utilization Project (HCUP), Agency for Healthcare Research and Quality, Rockville, MD, 2002, accessed Jan. 9, 2006, at: www.ahrq.gov/data/hcup/.
24. M.M. Issa, T.C. Fenter, L. Black, A.L. Grogg, and E.J. Kruep, "An Assessment of the Diagnosed Prevalence of Diseases in Men 50 Years of Age or Older," American Journal of Managed Care 12 (2006): S83-S89.
25. S.J. Loeb, "Older Men's Health: Motivation, Self-Ratings, and Behaviors," Nursing Research 53 no. 4 (2005): 198-206.
26. Y.T. Logan and M.T. Belgeri, "Monotherapy Versus Combination Drug Therapy for the Treatment of Benign Prostatic Hyperplasia," American Journal of Geriatric Pharmacotherapy 3 no. 2 (2005): 103-114.
27. D.M. Mannino, D.M. Homa, L. Akinbami, E.S. Ford, and S.C. Redd, "Chronic Obstructive Pulmonary Disease Surveillance - United States, 1971-2000," Morbidity and Mortality Weekly Report, Centers for Disease Control Surveillance Summaries 51 no. 6 (2002): 1-6.
28. MA/PDP Operational User Group, Call March 15, 2006, "Medication Therapy Management (MTM) Submissions Contract Year 2007," by Ketcham MB, accessed May 23, 2006, at: www.cpha.com.
29. E. McKinlay, "Men and Health: A Literature Review," Dunedin (New Zealand): 2005, accessed Jan. 9, 2006, at: www.nhc.govt.nz/PHAC/ publications/mens-health-literature-review.doc.
30. National Center for Health Statistics, National Health and Nutrition Examination Survey 1999-2000, Hyattsville (MD): Centers for Disease Control, 2000, accessed Jan. 9, 2006, at: www.cdc.gov/nchs/about/major/nhanes/ nhanes99_00.htm.
31. J.E. Oesterling, "Benign Prostatic Hyperplasia: A Review of Its Histogenesis and Natural History," Prostate 6 (1996): 67-73.
32. A. Plasencia, A.M. Ostfeld, and S.B. Gruber. "Effects of Sex on Differences in Awareness, Treatment, and Control of Blood Pressure," American Journal of Preventive Medicine 4 (1998): 315-326.
33. U. Sambamoorthi, D. Shea, and S. Crystal, "Total and Out-of-Pocket Expenditures for Prescription Drugs Among Older Persons," The Gerontologist 43 no. 3 (2003): 345-359.
34. D. Smith, "The Older Population in the United States: Population Characteristics," Current Population Reports, P20-546, Washington, DC: US Census Bureau, 2002, accessed Jan. 9, 2006 at: www.census.gov/prod/2003pubs/ p20-546.pdf.
35. M.J. Sorrentino, "Cholesterol Reduction to Prevent CAD: What Do the Data Show?" Postgraduate Medicine 108 no. 7 (2000): 40-52.
36. I.M. Thompson, D.K. Pauler, P.J. Goodman, C.M. Tangen, M.S. Lucia, H.L. Parnes, et al., "Prevalence of Prostate Cancer Among Men with a Prostate Specific Antigen Level of ≤4.0ng per Milliliter," New England Journal of Medicine 350 (2004): 2239-2246.
37. US Census Bureau, "Annual Estimates of the Population by Selected Age Groups and Sex for the United States: April 1, 2000, to July 1, 2005," Publication Number NC-EST2005-02, Washington, DC, 2005, accessed May 17, 2006, at: www.census.gov/popest/national/asrh/NC-EST2005-sa.html.
38. J.T. Wei, E. Calhoun, and S.J. Jacobsen, "Urologic Diseases in America Project: Benign Prostatic Hyperplasia," Journal of Urology 173 no. 4 (2005): 1256-1261.
39. J.L. Wolff, B. Starfield, and G. Anderson, "Prevalence, Expenditures, and Complications of Multiple Chronic Conditions in the Elderly," Journal of the American Medical Association, 162: 2269 (2002).
40. A. Zabalegui, "Aging Matters: Barriers to Health," Nursing Times 90 no. 1 (1994): 58-61.